EMD-52255

Single-particle
2.0 Å
EMD-52255
3D View Gallery
Deposition: 04/12/2024
Map released: 17/12/2025
Last modified: 17/12/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-52255
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 9hli summary report (pdf.gz) Map and 9hli FULL report (pdf.gz)
EMICSS annotations (xml)

Influenza Neuraminidase in complex with N-Acyl Oseltamivir inhibitor

EMD-52255

Single-particle
2.0 Å
EMD-52255
3D View Gallery
Deposition: 04/12/2024
Map released: 17/12/2025
Last modified: 17/12/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Influenza A virus
Sample: Influenza Neuraminidase in complex with N-Acyl Oseltamivir inhibitor
Fitted models: 9hli

Deposition Authors: Moran E , Davies G

Oseltamivir aziridines are neuraminidase imaging agents and potent anti-influenza agents
Moran E , Vriends M , Calvelo M , Hansen T , Pickles I, Xin X, Biezeno M, Armstrong Z, Ferras M, Li L, Lilley A, Harvey R, Schroder S, Van der Marel G, Artola M , Aerts J , Blaza J, Rovira C , Codee J , Overkleeft H , Davies G
To Be Published
Grant Support: